Literature DB >> 15093615

NF-kappaB-inducing kinase restores defective IkappaB kinase activity and NF-kappaB signaling in intestinal epithelial cells.

Maria Pia Russo1, Robert F Schwabe, R Balfour Sartor, Christian Jobin.   

Abstract

Cytokine-stimulated IkappaBalpha degradation is impaired in HT-29 and primary intestinal epithelial cells. To gain more insight into the mechanism of this defect, we dissected cytokine-induced NF-kappaB signaling pathway in HT-29 cells. IL-1beta and TNF, alone or in combination with IFNgamma, failed to induce IkappaBalpha or IkappaBbeta degradation in HT-29 cells. Despite similar 125I-IL-1beta binding, HT-29 cells displayed no IRAK degradation, a 75% reduction of IKK activity, and decreased IkappaBalpha phosphorylation, NF-kappaB DNA binding activity and IL-8 mRNA accumulation in response to IL-1beta compared to Caco-2 cells. Selective activation of NF-kappaB pathway by adenoviral delivery of NF-kappaB-inducing kinase (Ad5NIK) or IKKbeta (Ad5IKKbeta) strongly activated IKK activity (>20 fold) in HT-29 cells with concomitant endogenous IkappaBalpha serine 32 phosphorylation and total IkappaBalpha degradation. In addition, NF-kappaB DNA binding activity and IL-8 secretion is higher in Ad5NIK-infected than in IL-1beta-stimulated HT-29 cells. These data show that altered NF-kappaB signaling is associated with impaired stimulation of an upstream IKK activator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093615     DOI: 10.1016/j.cellsig.2003.11.007

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells.

Authors:  J S Kim; A S Narula; C Jobin
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

3.  Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells.

Authors:  Sen Rong Yan; Robbie Randle Joseph; Kirill Rosen; Mauricio J Reginato; Amanda Jackson; Norman Allaire; Joan S Brugge; Christian Jobin; Andrew W Stadnyk
Journal:  Oncogene       Date:  2005-09-29       Impact factor: 9.867

4.  The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells.

Authors:  Chie Nishioka; Takayuki Ikezoe; Jing Yang; Keiko Udaka; Akihito Yokoyama
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

5.  The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells.

Authors:  Joo Sung Kim; Christian Jobin
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

Review 6.  NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis.

Authors:  Bingran Wang; Jun Shen
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

7.  Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells.

Authors:  Lobke Snoeks; Christopher R Weber; Jerrold R Turner; Mitra Bhattacharyya; Kaarin Wasland; Suzana D Savkovic
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells.

Authors:  D Haller; L Holt; A Parlesak; J Zanga; A Bäuerlein; R B Sartor; C Jobin
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

9.  Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.

Authors:  Vicenç Ruiz de Porras; Sara Bystrup; Anna Martínez-Cardús; Raquel Pluvinet; Lauro Sumoy; Lynne Howells; Mark I James; Chinenye Iwuji; José Luis Manzano; Laura Layos; Cristina Bugés; Albert Abad; Eva Martínez-Balibrea
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.